Skip to main navigation

Technology    Investor Relations    Company     Careers     Customer Service

Advancing Diagnostics to Improve Cancer Treatments Navigation
  • Patients/Caregivers
  • Medical Professionals
  • Partners

Investor Relations

Investor Relations

  • Overview
  • Press Releases
  • Events & Presentations
  • Financial Information
  • Stock Information
  • Corporate Governance
  • Investor FAQs
  • Contact Us

Shareholder Tools

  • Email Alerts Subscription
  • Download Library
  • Print
  • Share
  • Facebook
  • Google
  • LinkedIn
  • Twitter
  • RSS

SEC Filing Details

Document Details

Form
10-K
Filing Date
Mar 28, 2018
Document Date
Dec 31, 2017
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Biocept Inc.
Issuer
BIOCEPT INC

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.INS - XBRL INSTANCE DOCUMENT
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
Investor Relations Company Careers Customer Service
Contact Biocept, Inc.

Biocept, Inc. Headquarters
5810 Nancy Ridge Drive, Suite 150
San Diego, CA 92121
Investor Relations: 858.320.8244
Fax: 858.320.8225
Email: info@biocept.com

Connect With Us

Important Links

Patients/Caregivers   |    Medical Professionals   |   Partners   |   Contact Us


  • Careers
  • Company
  • Customer Service
  • Technology
  • Privacy Policy
  • Terms of Use
  • Contact Us

© 2019 Biocept, Inc. All rights reserved.